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The placenta is at the core of many pregnancy pathologies, but we have limited knowledge about placental
function because of two key research barriers: 1) lack of guidelines for sample collection and pathologic diag
nosis; and 2) limited tools are available for molecular analysis of stored placental samples. We aimed to create a
searchable, population-based placental database of pathologic diagnoses, and to validate molecular methods for
gene expression studies of matching formalin fixed paraffin embedded (FFPE) placental blocks. Our database has
over 1000 pregnancies coded for clinical diagnosis with corresponding FFPE blocks that are available for gene
expression studies. RNA harvested from FFPE tissues is of sufficient quality for downstream applications. We
successfully used this pipeline to identify FFPE placenta from term and preterm pregnancies, and compared their
gene expression. The establishment of this platform, which links clinicopathological data and molecular gene
expression, will increase our understanding of obstetrical diseases.

1. Introduction
Archival formalin fixed paraffin embedded (FFPE) tissues are a stable
and inexpensive source of genetic material. Archived pathology samples
have been successfully used for advanced gene expression research in
many organs, but not in the human placenta. The George Washington
University (GWU) has a collection of placental FFPE blocks from every
pregnancy between 2012 and 2017, but their utility for molecular
studies has not been systematically validated. We describe a new pipe
line for clinicopathological and molecular assessment of existing,
archived FFPE placental samples which 1) employs a new database of
clinicopathological electronic medical records (EMRs) and 2) utilizes
FFPE placenta for downstream gene expression analyses. We exploit this
pipeline to query the gene expression differences between term and
preterm placenta using RNA-sequencing.
2. Materials and methods
Per hospital policy between 2012 and 2017, the placenta from each
delivery was sent for pathological examination. GWU’s placental
archive of >15,000 samples contains the following sections from these
deliveries: one block with 2 umbilical cord sections and amniotic

membrane roll, 2 blocks with full sections (maternal and fetal aspects) of
the placental disc (central), and additional sections if there were gross
abnormalities. GWU keeps FFPE blocks for 10 years.
Clinical data from pregnancies (maternal and fetal EMR) were
extracted from the GWU’s Cerner EMR and entered into an IRB approved
REDCap database. Placental pathology was re-scored by an expert
pathologist and entered into the database following the “Amsterdam
Consensus Guidelines” [1].
To acquire matched frozen and FFPE tissues, women were prospec
tively screened for uncomplicated pregnancy and delivery. Upon de
livery, full thickness, central tissue cores of the placental disc were snapfrozen and stored at − 80 ◦ C; the remaining placenta was processed as
standard FFPE blocks for pathological assessment. Placenta were kept at
room temperature and underwent two stages of formalin fixation – first
in the delivery room, within 30–60 min of placenta delivery, and then
again in the gross room. Length of fixation was variable, ranging from 1
to 3 days, depending on whether delivery occurred on a weekday or
weekend. Only placenta without gross lesions or significant pathologic
abnormalities were included in the study and matched with their frozen
specimens.
After validation of our methods for FFPE tissues, 10 term and 10
preterm cases, defined as delivery before 34 weeks, were identified
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using our database.
We used standard kits and reagents for RNA isolation, cDNA syn
thesis, qRT-PCR and immunostaining, and followed manufacturers’
protocols. A detailed list of reagents, equipment, statistics, and primers
can be found in Supplementary data.
RNA-sequencing was done by LC Sciences (Houston, TX). Details can
be found in Supplementary data.

Table 1
Database demographic information and common pregnancy complications.
Cohort information for the term and preterm samples included in the RNA-seq.
Database Information
Criteria

% in
population

Race
Black
White
Other
Ethnicity
Hispanic
Non-Hispanic
Body Habitus (body mass index, BMI)
Normal, BMI less than 25
Overweight, BMI within 25 and 30
Obese, BMI greater than 30
Gestational Age
Term, 37 weeks or more
Preterm, less than 37 weeks
Pathology condition
Chorioamnionitis
Fetal inflammatory response
Maternal stromal vascular lesions
Menconium-Related changes
Intervillous thrombi
Gestational hypertensive disorders
Gestational diabetes

3. Results and discussion
Placental dysfunction is at the core of many pregnancy complica
tions, yet our understanding of obstetrical diseases and their impact on
child health is limited by a lack of tools to study the placenta. Since FFPE
placenta are a potential goldmine of genetic material, that can be linked
to EMRs, we sought to create a pipeline whereby clinicopathological
questions could be investigated.
Our database of >1000 cases, is founded on a unique, populationbased dataset that includes placenta and EMRs from both complicated
and normal term pregnancies. Cases are coded for patient demographic
data; gross (macroscopic) and microscopic placental pathology findings;
gestational age; antenatal conditions and onset; pre- peri- and postpregnancy status; and fetal outcomes (Table 1). Since GWU is located
in the urban metropolis of Washington, D.C., this database is represen
tative of the diverse populations of the community. Matching of
maternal and fetal EMRs with systematic placental pathology reports
into a searchable database now allows for interrogation of obstetric
clinical questions, by enabling easy sample identification of the corre
sponding FFPE placental blocks.
It was previously unclear whether FFPE human placental blocks were
useful for downstream genetic analysis and comparable to fresh frozen
tissues since placental core sections are particularly thick and fibrous,
limiting their solubility and requiring prolonged formalin fixation that
can potentially degrade RNA [2–4]. Approximately 6 μg of RNA was
obtained per 20 μm slice of FFPE placenta tissue. 260/280 absorbance
ratios were ~2 for all samples, indicative of pure RNA. Quality of FFPE
RNA (RNA integrity number, RIN, 2.38 ± 0.04, n = 20) was significantly
lower (t (1,38) = 74.12, p < 0.0001) than matched frozen RNA frozen
tissues (9.68 ±0 .09, n = 20) and published values from fresh or
RNA-later stored placenta [5,6]. Comparing RNA from FFPE placenta to
RNA-later stored tissues is an important line of future work since
RNA-later is superior to snap-freezing [5,6], and both methods of RNA
stabilization likely provide higher RNA quality than FFPE extraction
can. However, clinical samples continue to be stored in FFPE. Although
lower RINs can result in higher qRT-PCR cycle threshhold (Ct) values [5,
6], the expression level of only 8% of placental genes are dependent on
RIN [7] and there are methods to correct for differences in sample
degradation [8]. Notably, RIN values are similar in FFPE tissues stored
over time [9]; thus, samples identified using our pipeline likely undergo
similar degrees of degradation and are suitable for comparison to one
another. Moreover, RINs of ~2.4 are similar to that of long-term stored,
snap-frozen placenta where Cts were detectable [5,6], and are par with
RNA harvested from other FFPE tissues types, where RINS above 1.4
were successfully used in gene expression assays [10,11]. To our
knowledge, no other method for FFPE tissues consistently returns higher
RINs [12].
Confirming the quality of RNA, known placental housekeeping genes
Ywhaz, Cyc1, and Top1 [13,14] were detected in every FFPE sample,
demonstrating that RNA degradation did not preclude qRT-PCR
(Fig. 1A). Variability in Ct increased in proportion to gene length,
possibly due to reduced transcript stability [7] and increased mRNA
fragmentation. However, comparable Cts between fresh frozen and FFPE
RNA suggest that expression in FFPE placenta tissues is representative of
placental expression, and is consistent with findings from other tissues
where snap frozen and FFPE processed samples’ gene expression
correlate strongly (r = ~0.9 [11,15,16]). Identification of these house
keeping genes in FFPE placenta allow for normalizing inter-sample

Summary of term and preterm cohorts
Criteria
Term
Gestational age
Sex of fetus (M/
F)
Delivery type
(VD/CS)
Obese
Chronic HTN,
PEC
Other delivery
indications

40%
47%
13%
9.2%
90.8%
37%
35%
28%
88%
12%
30.5%
19.0%
18.0%
18.0%
12.0%
10.0%
3.4%
Preterm

p-value

~39.8.5 ± 0.3
3/7

~26.5 ± 1.3
6/4

<0.0001
0.178

5/5

7/3

0.361

2
0

2
2

>0.999
0.136

Breech (2)

Non-reassuring
fetal heartrate (1)

Cervical insufficiency
or short cervix (5)
h/o LEEP (1)
Intrauterine fetal
demise (1)
Non-reassuring fetal
heartrate (1)
Placental abruption (2)
PPROM 3)
Precipitous delivery (1)

VD: vaginal delivery.
CS: caesarian section.
Chronic HTN, PEC: Chronic hypertension and preeclampsia with severe features.
PPROM: preterm premature rupture of membranes.
h/o LEEP: history of loop electrosurgical excision procedure.
Data analyzed by Chi-squared test and student t-test for categorical and para
metric data, respectively.

loading variability [17,18] and make qRT-PCR analysis feasible.
We identified term and preterm FFPE placentas using our database
(Table 1) and successfully performed gene expression analysis by RNAsequencing, which was then validated by qRT-PCR (Fig. 1B–E). There
were 1394 upregulated and 2235 downregulated genes in preterm
placenta compared to term (Fig. 1F). Hierarchical clustering reveals
distinct expression signatures between term and preterm placenta, that
cluster closely within their groups (Fig. 1G). Notably, our findings agree
with microarray data from second trimester versus term, fresh, frozen,
human placenta. For genes that are significantly dysregulated in both
datasets, there is an ~87% concurrence in the fold change direction
[19]. High gene overlap, despite methodological differences, indicates
the validity of placental FFPE for RNA-seq.
A greater proportion of down-regulated differentially expressed
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Fig. 1. FFPE RNA is suitable for downstream gene expression analysis
(A) Comparison of matched fresh frozen and FFPE placenta by qRT-PCR. FFPE tissues express known placental housekeeping genes, Ywhaz, Top1, and Cyc1 at levels
comparable to fresh frozen (F (1,55) = 0.7326, p = 0.396). There was a main effect of gene (F (2,55) = 9.314, p = 0.003) due to higher TOP1 expression than CYC1
and YWHAZ in FFPE tissues (p = 0.048 and p < 0.0001, respectively, Sidak’s). (B–C) Validation of select DEGs identified in the RNA-seq by qRT-PCR. Consistent with
the RNA-seq, Dusp9 and Efemp1 were significantly upregulated preterm placenta (t (17) = 2.465, p = 0.025 and t (16) = 3.871, p = 0.001, respectively). (D-E) In a
second cohort of preterm and term placenta, both genes were significantly upregulated (t (13) = 2.739, p = 0.017 for Dusp9 and t (10) = 2.382, p = 0.039 for
Efemp1). (F) Volcano plot of 1394 upregulated genes (red) and 2235 downregulated genes (blue) in preterm placenta. (G) Hierarchical clustering of the top 100
DEGs. (H) Significant KEEG pathways, with p value represented by color, and the number of genes represented by the circle size. Rich factor is the ratio of the DEG
number to the background number for a specific KEGG pathway.

genes (DEGs) may reflect premature loss of late-gestation placental
factors, exhibited by disruptions to cell cycling and steroid biosynthesis
(Fig. 1H), which are gestationally regulated processes [20,21]. Placenta
steroid disruption is one pathway significantly disrupted in preterm
birth that deserves further investigation [22]. Alcoholism and systemic
lupus erythematosus (SLE) were the most represented pathways and are
known risk factors for preterm delivery [23,24]. Likely the DEGs in
alcoholism and SLE overlap with genes related to inflammation and
maternal immune activation, which are comorbidities for some of the
clinical conditions indicated in our preterm cohort.
Our novel pipeline presents a non-bias method to examine placental
functions associated with preterm birth and other obstetric complica
tions. The creation of this database combined with validation of FFPE
placenta samples as suitable genetic material provides a tool for

identifying biomarkers and pathways for further investigation.
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